Get the Stockscreener App
1.22
0.00%
0.00
Pharmacyte Biotech Inc stock is traded at $1.22, with a volume of 850.75K.
It is up +0.00% in the last 24 hours and up +43.19% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$1.22
Open:
$1.17
24h Volume:
850.75K
Relative Volume:
0.28
Market Cap:
$8.02M
Revenue:
-
Net Income/Loss:
$-1.13M
P/E Ratio:
-2.6574
EPS:
-0.4591
Net Cash Flow:
$-4.60M
1W Performance:
+62.69%
1M Performance:
+43.19%
6M Performance:
+19.61%
1Y Performance:
-25.61%
1-Day Range:
$1.06
$1.19
1-Week Range:
$0.712
$1.51
52-Week Range:
$0.63
$1.90
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.04 | 4.64B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.207 | 469.42M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.03 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.6624 | 201.10M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.90 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
Healthy Upside Potential: PharmaCyte Biotech Inc (PMCB) - Setenews
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice - TipRanks
PharmaCyte Biotech’s Potential Explored Amidst Market Movements - timothysykes.com
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
Why PharmaCyte Biotech Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Down 6.1% – Here’s What Happened - Defense World
Take off with PharmaCyte Biotech Inc (PMCB): Get ready for trading - Setenews
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Is PharmaCyte Biotech Inc a good long term investmentVolatility Adjusted Trading & High Profit Market Ideas - earlytimes.in
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech - The Pharma Letter
PharmaCyte Biotech successfully monetizes Femasys stake - The Pharma Letter
Check Out PharmaCyte Biotech Inc (PMCB)’s Trade Data Rather Than the Analysts’ Views - Setenews
A History of Outperforming Analyst Forecasts and Beating the Odds: Clean Energy Technologies Inc (CETY) - Setenews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
PharmaCyte Biotech (PMCB) Stock: Increases Cash and Securities to $20M Strengthening Balance Sheet - parameter.io
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - Asianet Newsable
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech, Inc. (PMCB) 17.97% in Intraday Trading: Success in Monetization Bolsters Financial Position - Stocks Telegraph
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million By Investing.com - Investing.com South Africa
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Pancreatic Cancer Precision Medicine Market Size to Hit USD 4,030.16 Mn by 2034 - Precedence Research
PharmaCyte Biotech Amends Equity Incentive Plan - MSN
Is Simplify Health Care ETF stock good for wealth creationMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Nuvilex (NASDAQ:PMCB) Shares Down 3% – Should You Sell? - Defense World
Is PharmaCyte Biotech Inc. forming a bottoming baseJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Combining machine learning predictions for PharmaCyte Biotech Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Statistical indicators supporting PharmaCyte Biotech Inc.’s strength2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
[8-K/A] PharmaCyte Biotech, Inc. Amends Material Event Report | PMCB SEC FilingForm 8-K/A - Stock Titan
What sentiment indicators say about PharmaCyte Biotech Inc. stock2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
What Fibonacci levels say about PharmaCyte Biotech Inc. rebound2025 Winners & Losers & Long-Term Growth Plans - newser.com
Applying chart zones and confluence areas to PharmaCyte Biotech Inc.Weekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
Can PharmaCyte Biotech Inc. recover in the next quarterWeekly Investment Report & Fast Momentum Entry Tips - newser.com
How PharmaCyte Biotech Inc. stock performs in stagflationAnalyst Downgrade & Accurate Buy Signal Alerts - newser.com
Head to Head Review: PharmaCyte Biotech (OTCMKTS:PMCBD) and Alpha Cognition (OTC:ACOGF) - Defense World
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):